Eccentric cardiac remodeling seen in dilated cardiomyopathy or regurgitant valvular disease is a well-known process of heart failure progression, but its mechanoenergetic profile has not been yet established. We made a volume overload (VO) heart failure model in rats and for the first time investigated left ventricular (LV) mechanical work and energetics in cross-circulated whole heart preparations. Laparotomy was performed in 14 Wistar male rats, and abdominal aortic-inferior vena caval shunt was created in seven rats (VO group). Another seven rats underwent a sham operation without functional shunt (Sham group). LV dimensions changes were followed with weekly transthoracic echocardiography. Three months after surgery, we measured LV pressure and volume and myocardial O2 consumption in isolated heart cross circulation. LV internal dimensions in both systolic and diastolic phases were significantly increased in the VO group versus the Sham group (P Ͻ 0.05). LV pressure was markedly decreased in the VO group versus in the Sham group (P Ͻ 0.05). LV end-systolic pressurevolume relation shifted downward, and myocardial O2 consumption related to Ca 2ϩ handling significantly decreased. The contractile response to Ca 2ϩ infusion was attenuated. Nevertheless, the increase in Ca 2ϩ handling-related O2 consumption per unit change in LV contractility in the VO group was significantly higher than that in the Sham group (P Ͻ 0.05). The levels of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a protein were reduced in the VO group (P Ͻ 0.01). In conclusion, VO failing rat hearts had a character of marked contractile dysfunction accompanied with less efficient energy utilization in the Ca 2ϩ handling processes. These results suggest that restoring Ca 2ϩ handling in excitation-contraction coupling would improve the contractility of the myocardium after eccentric cardiac remodeling. eccentric left ventricular hypertrophy; myocardial oxygen consumption; Ca 2ϩ handling; sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a; cross circulation; aortocaval shunt HEART FAILURE IS A MAJOR CAUSE of mortality and morbidity. It is due to various diseases such as hypertension, ischemic heart disease, valvular heart disease, congenital heart disease, cardiomyopathy, myocarditis, and others. The heart is subject to excessive and/or long-term overload, which induces myocardial hypertrophy. Hypertrophy initially compensates cardiac function but finally leads to heart failure. The process of hypertrophy and heart failure progression is divided into two mechanisms, depending on the type of overload: pressure overloading (PO) and volume overloading (VO). PO induces concentric hypertrophy to normalize wall stress from the increase in pressure placed on cardiomyocytes. Concentric remodeling of the left ventricle (LV) is characterized by an increase in ventricular wall thickness due to vertical growing of cardiomyocytes, which is caused by the parallel addition of sarcomeres (8).
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Conversely, VO promotes eccentric hypertrophy to compensate for excess blood volume in the LV chamber. Eccentric remodeling of the LV is characterized by a relatively small increase in wall thickness and longitudinal growing of cardiomyocytes.
Morphological analyses, functional studies using echocardiography (4), and molecular studies (10) have been conducted on both PO and VO rat hearts. However, the cardiac mechanoenergetics studies have not yet been well conducted. We have established a method to analyze specifically the LV mechanical work and energetics in an excised, blood-perfused whole heart preparation with a cross-circulation method (7, 14, 17, 19, 20, 24) and analyzed LV mechanoenergetics in a PO heart failure model.
In the present study, we focused on the investigation of the mechanical work and energetics in a VO heart failure model with an arteriovenous (AV) shunt in rats.
MATERIALS AND METHODS

Animals
All animal experiments were performed with the approval of the Animal Care Committee of the Massachusetts General Hospital and the Mount Sinai School of Medicine and in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Fourteen male Wistar rats (Charles River, MA) weighing 300 -350 g were randomized into two groups: 1) rats subjected to abdominal aortocaval shunt procedures as described previously (VO rats, n ϭ 7) (22) and 2) Sham-operated rats (Sham rats, n ϭ 7).
Creation of the Animal Models
VO was induced via the aortocaval shunt method (5, 22) . All rats were anesthetized for surgery with intraperitoneal injection of 50 mg/kg pentobarbital sodium. After endotracheal intubation, artificial ventilation was initiated. Heparin (200 units ip) was added to prevent thrombosis during aortic and vena caval occlusion and promote shunt patency. Ventral laparotomy was performed, and the abdominal aorta and inferior vena cava were exposed by blunt dissection between the renal arterial branch and the iliac bifurcation. Both vessels were temporally occluded at both proximal and distal sites of the intended shunt point with a Bulldog clip. An 18-gauge angio-catheter was inserted over a needle into the exposed free wall of the abdominal aorta and advanced through the medial wall into the vena cava to create the shunt. After the needle and the angio-catheter were withdrawn, the ventral aortic puncture site was sealed with a drop of cyanoacrylate (Krazy Glue; Elmer's Product Canada, Toronto, Ontario, Canada) to prevent or stop bleeding from the aortic puncture site. Successful shunt could be confirmed by seeing the mixing of oxygenated blood into the vena cava from the abdominal aorta. Sham-operated animals served as controls and were subjected to the same surgeries but had no functional shunt.
Echocardiography
Cardiac function after shunt creation was monitored weekly with transthoracic echocardiography (M mode and pulse wave Doppler) using a Vivid 7 ultrasound system (GE Healthcare, Waukesha, WI) equipped with a 14-MHz transducer under sedation with a low dose (25 mg/kg ip) of pentobarbital sodium. An M-mode pacing of the LV was obtained from the parasternal short-axis view at the level of the papillary muscles. M-mode recordings were then analyzed at a sweep speed of 150 mm/s with the axis of the probe aligned with the middle of the ventricle. The following parameters were measured and calculated using the leading edge method described by the American Society of Echocardiography (4, 12): LV internal dimensions (LVID) at both diastole and systole (LVIDd and LVIDs, respectively), LV posterior wall dimensions at both diastole and systole, interventricular septal (IVS) dimensions at both diastole (IVSd) and systole, heart rate (HR), percentage of LV fractional shortening, LV ejection fraction (EF), and cardiac output.
LV Mechanical and Energetic Studies
Surgical preparations. LV mechanical and energetic studies were performed 3 mo after the creation of aortocaval shunt on the excised cross-circulated rat heart preparations, as reported previously (13) . In each experiment, one VO or Sham rat and two retired breeder male crj:Wistar rats weighing 450 -650 g were anesthetized with pentobarbital sodium (50 mg/kg ip), intubated, and ventilated. The study rat (VO or Sham) was used as heart donor, and the other two were used as blood supplier and metabolic supporter rats, respectively. All rats were heparinized (1,000 units intravascular). The beating donor heart was excised without an interruption of coronary perfusion and supported by cross circulation with the other metabolic supporter rat as previously reported in detail (7, 14, 17, 19, 24) . The coronary arterial oxygenated blood of the donor heart was supplied from the common carotid arteries of the supporter rat using arterial cross-circulation tubing and a cannula inserted into the brachiocephalic artery of the donor heart. The coronary venous blood of the donor heart was collected from a cannula inserted into the right ventricle (RV) via the superior vena cava and the right atrium and returned to the right external jugular vein of the supporter rat using venous cross-circulation tubing and a cannula. The excised heart was maintained at 37°C by a heater. A thin latex balloon (balloon material volume, 0.08 or 0.10 ml) was inserted from the left atrial appendage into the LV and primed with water. The maximum unstretched volume of the used balloon was large enough to exceed measured end-diastolic volume in both VO and Sham rat hearts. The balloon was connected to a 0.5-ml precision glass syringe with fine scales (minimum scale, 0.005 ml) to allow changing LV volume (LVV) in 0.025-ml steps and also connected to a pressure transducer for measuring LV pressure (LVP) measurement. LVV was increased in steps up to an end-diastolic pressure (EDP) of around 10 mmHg in the control volume run. Systolic unstressed volume (V 0) was determined by filling the balloon to the level where peak isovolumic pressure and hence pressurevolume area (PVA; see Data Analysis) were zero. The sum of intraballoon water volume and balloon material volume was used as an initial estimate of V 0. V0 normalized by LV mass to 1 g was then finally determined as the volume-axis intercept of the best-fit endsystolic pressure (ESP)-volume relation (ESPVR). We obtained the best-fit ESPVR with an equation (ESP ϭ A{1Ϫexp[ϪB(VϪV 0)]}; A and B are parameters) by means of the least-squares method (DeltaGraph, DeltaPoint; Monterey, CA) on a personal computer (14, 17, 19, 24) . We also obtained the best-fit EDP-volume relation (EDPVR) with an equation (EDP ϭ AЈ{exp[BЈ(VϪV 0)]Ϫ1}; AЈ and BЈ are parameters). Correlation coefficients of the best-fit ESPVRs were higher than 0.98 ( Table 1) .
The HR was constantly maintained by electrical pacing of the right atrium, and the pacing rate was adjusted around 300 beats/min to avoid causing incomplete relaxation or arrhythmia. The systemic arterial blood pressure of the supporter rat served as the coronary perfusion pressure (90 -120 mmHg). Arterial O 2 saturation and O2 content of the supporter rat were monitored with an oximeter (model IL682 CO-Oxymeter; Instrumentation Laboratory) and maintained within their physiological ranges with ventilation adjustment and supplemental O 2 and sodium bicarbonate.
Calculation of O2 consumption. Total myocardial O2 consumption per beat (V O2) was obtained as the product of coronary flow and coronary AV O2 content difference (AVO2D) divided by the pacing rate (300 beats/min) (14, 17, 19, 24) . Total coronary blood flow was continuously measured with an ultrasonic flowmeter (model T206; Transonic System, Ithaca, NY) placed in the middle of the venous drainage tubing from the RV. LV thebesian flow is negligible. The coronary AVO 2D was continuously measured by passing all the arterial and venous cross-circulation blood through the cuvettes of a custom-made AVO 2D analyzer (PWA-200S, Shoe Technica; Chiba, Japan) as previously reported in detail (14, 17, 19, 24) .
Calculation of PVA. PVA was defined as the systolic PVA circumscribed by the curvilinear ESPVR, the EDPVR, and the systolic portion of the ventricular pressure-volume trajectory and was obtained by the integration of ESPVR and EDPVR. The areas under the ESPVR and EDPVR were obtained by the integration of the best-fit exponential functions. Based on our previous publications (14, 17, 19, 24) , we obtained control ESPVR and determined a midrange LV volume (mLVV) under which contractility changes in response to Ca 2ϩ infusion (16) . As the balloon volume generally changed between 0 and 0.10 ml in Sham rats and between 0 and 0.20 ml in VO rats, respectively, we adopted mLVV normalized by LV mass to 1 g at balloon volume of 0.05 ml for Sham LVs and at balloon volume of 0.10 ml for VO LVs. We calculated ESP at mLVV (ESP mLVV) and PVA at mLVV (PVAmLVV) to assess LV mechanical work and energetics in the two groups.
As shown previously (14, 17, 19, 24) , the V O2-PVA relationship was linear in the rat LV. Its slope represents the O2 cost of PVA, and its V O2 intercept represents the PVA-independent V O2. The PVAindependent V O2 is composed of V O2 in excitation-contraction (E-C) coupling (18) and basal metabolism (11, 17) . The RV was kept collapsed (and therefore unloaded) by continuous hydrostatic drainage of the coronary venous return so that the RV PVA and hence PVA-dependent V O2 were assumed to be negligible (19, 20) . The RV component of total V O2, which is considered constant irrespective of LV volume, was calculated by multiplying biventricular V O2 under unloaded LV volume with the ratio of the RV weight divided by the sum of the RV and LV weight. The RV PVA-independent V O2 (14, 17, 19, 24) was subtracted from the total V O2 to yield LV V O2 expressed as V O2. The LV (including the septum) and the RV were weighed at the end of the experiment for normalization of LVV.
Experimental protocol. LVP, LV V O2, and systolic PVA data were obtained at more than five different LV volumes from 0 to 0.2 ml of intraballoon volume in 0.025-ml increments, without inotropic interventions [control volume-loading run (vol-run)]. After the vol-run, the Ca 2ϩ inotropic run (Ca 2ϩ ino-run) was performed at an mLVV by intracoronary infusion of 1% CaCl2 solution. The infusion rate of CaCl2 solution was increased stepwise from 0 to 6 ml/h. Steady-state V O2 was reached 2 to 3 min after change of LV volume and 4 min after change of infusion rate. Finally, cardiac arrest was induced by intracoronary infusion of 1 M KCl (12 ml/h) to obtain O 2 consumption for basal metabolism. At each steady state, data were sampled at 500 Hz for 2 s simultaneously, and the sampling was usually repeated three times at 0.5-to 1-min intervals.
Data Analysis
V O2 for Ca 2ϩ handling during the Ca 2ϩ ino-run. In previous mechanoenergetic studies in excised rat hearts (14, 17, 19, 24) , a linear V O2-PVA relation obtained during Ca 2ϩ infusion (Ca 2ϩ V O2-PVA relation) was shifted upward in parallel with the control V O2-PVA relation before Ca 2ϩ infusion. Such parallelism was also observed in VO rat hearts in our preliminary experiments. The V O2-intercept (PVA-independent V O2) corresponds primarily to the V O2 for Ca 2ϩ handling in E-C coupling and for basal metabolism (11, 17, 18) . The increased V O2 intercept of the Ca 2ϩ V O2-PVA relation is attributable to the increased V O2 for enhanced Ca 2ϩ handling due to the unchanged V O2 for basal metabolism (17) . Thus, at increasing levels of inotropy, the intercept of the V O2-PVA relationship increases, but the slope remains unchanged. Based on this parallelism, the lines of V O2-PVA linear relationships at different rates of Ca 2ϩ infusion at an mLVV were drawn in parallel to the control V O2-PVA relation line, as described previously (14, 17, 19, 24) .
During the Ca 2ϩ ino-run at an mLVV, ESPVR curves at different infusion rates were obtained as best-fit exponential function curves.
We calculated PVA mLVV during Ca 2ϩ infusion on a personal computer (14, 17, 19, 24) . We then obtained the two composite V O2-PVAmLVV data points. After we drew the lines, including each V O2-PVAmLVV data point, in parallel to the control V O2-PVA relation, we obtained the V O2 intercept at each infusion rate. We subtracted basal metabolic V O2 per beat, measured in KCl-arrested hearts, from PVA-independent V O2 to obtain V O2 for Ca 2ϩ handling in E-C coupling.
LV contractility. Our recently proposed index for LV contractility (i.e., equivalent maximal elastance [eE max]) was calculated from ESP-volume ratio of the specific virtual triangular area, which is energetically equivalent to PVA mLVV as previously described (17, 20) .
O 2 cost of LV contractility. The O2 cost of LV contractility was obtained as the slope of the linear relation between V O2 for Ca 2ϩ handling in E-C coupling and eEmax at an mLVV during the Ca 2ϩ ino-run. At every infusion rate, there was a corresponding eEmax and a corresponding V O2 for Ca 2ϩ handling in E-C coupling derived from the V O2-PVA intercept (PVA-independent V O2). eEmax and PVAindependent V O2 were also linearly related. The slope of the latter linear relationship, defined as the O2 cost of LV contractility, quantifies the change in V O2 for Ca 2ϩ handling per unit change in LV contractility.
Western blot for sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a and sodium-calcium exchanger proteins. LV myocardium from each heart was frozen and stored at Ϫ80°C after the mechanoenergetic studies. The frozen hearts were thawed and homogenized. The homogenates were matched for protein concentration, subjected to SDS-PAGE, and transferred to nitrocellulose membranes. For immunoreactions, the blots were incubated with primary antibodies to sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a (SERCA2a; Affinity Bioreagents, Golden, CO), sodium-calcium exchanger (NCX)1 [Chemicon (Millipore), Billerica, MA], and GAPDH (Sigma-Aldrich, St. Louis, MO) and then subjected to enhanced chemiluminescence for detection. Both SERCA2a and NCX1 expressions were normalized to GAPDH expression.
Statistical analysis. Values are means Ϯ SD. Comparison of paired and unpaired individual values was performed by the paired and unpaired t-test, respectively. A value of P Ͻ 0.05 was considered statistically significant. All data are expressed as the means Ϯ SD.
RESULTS
Echocardiography
Typical M-mode echocardiograms in both VO and sham rats 10 wk after operation are displayed in Fig. 1 . This trend continued up to 12 wk where VO rats exhibited chamber dilatation at diastole that reached 140% of that in Sham rats. The LVIDs in the VO group was significantly increased from 3 wk after shunt compared with that in the Sham group, then continued to increase gradually, and reached 150% of Sham rats after 9 wk. The delay means that the decreasing of cardiac contractility became notable 3 wk after shunt and took at least 9 wk to get worst. The EF in the VO group was increased for the first 2 wk after AV shunt creation and then decreased gradually, and the reduction less than Sham group was first noted at 6 wk. The IVSd in the VO group was slightly thinner compared with that in the Sham group. are shown. *P Ͻ 0.05 vs. Sham. As early as 2 wk after the surgery, LVIDd significantly increased in VO compared with Sham rats. This trend continued up to 12 wk where VO rats exhibited chamber dilatation in diastole that reached 140% of that in Sham rats. The LVIDs in the VO group was significantly increased from 3 wk after shunt compared with that in the Sham group, then continued to increase gradually, and reached 150% of that in Sham rats after 9 wk. The EF in the VO group was increased at first 2 wk after arteriovenous shunt but then decreased gradually to become less than Sham group at 6 wk. The IVSd in the VO group was slightly thinner compared with that in the Sham group. Post Op, postoperation of shunt creation or sham procedure. enlarged compared with that in the Sham group. Both the LV and RV weights in the VO group were significantly heavier than those in the Sham group (Table 1) .
Characterization of Hearts and Lungs
LV Contractility
Summarized data of LV mechanical work and energetics are shown in Table 2 . Figure 4 shows a representative data and best-fit curves of the ESPVR and EDPVR in both VO and Sham group. The LV ESPVR shifted downward, and thus the mean LV ESP mLVV was significantly decreased in the VO group compared with the Sham group (P Ͻ 0.01; Table 2 ), although the EDPVR did not shift upward. Figure 5 shows representative data and best-fit ESPVRs during the Ca 2ϩ infusion of both VO and Sham groups. The contractile response to Ca 2ϩ infusion at a given concentration was smaller in the VO group than that in the Sham group. The mean ␦ESP mLVV in the VO group was significantly smaller (P Ͻ 0.05) than that in Sham group (Table 2) .
LV Energetics
Summarized data of LV energetics are also shown in Table 2 . Figure 6 shows each set of representative V O 2 -PVA data and the best-fit V O 2 -PVA linear relations in VO and Sham hearts. The V O 2 intercept was smaller in this VO heart than in the Sham heart, but the slopes of both V O 2 -PVA relations were similar. The mean V O 2 intercept was significantly smaller in the VO group than that in the Sham group (Table 2) , but the mean slopes of V O 2 -PVA linear relations did not differ significantly between VO and Sham groups ( Table 2 ). Basal metabolism obtained by KCl arrest was unchanged in the VO and Sham groups (Table 2 ) and thus the significantly smaller V O 2 intercept in VO group was due to the decreased O 2 consumption associated with Ca 2ϩ handling in E-C coupling. Figure 7 shows each set of representative PVA-independent V O 2 -eE max,mLVV data and best-fit PVA-independent V O 2 -eE max,mLVV regression lines in both VO and Sham hearts. Each slope of the regression lines denotes the O 2 cost of LV contractility, an index quantifying the V O 2 for Ca 2ϩ handling per unit change in LV contractility, as mentioned in Data Analysis. The O 2 cost of LV contractility in this VO heart was higher than that in the Sham heart. The mean O 2 cost of LV contractility in the VO group was significantly higher (P Ͻ 0.05) than that in the Sham group ( Table 2) .
V O 2 -PVA Relationship
O 2 Cost of LV Contractility
Immunoblotting of SERCA2a and NCX Normalized to GAPDH
The mean protein level of SERCA2a in VO rat hearts was significantly lower (P Ͻ 0.01) than that in Sham rat hearts (Fig. 8) . We also observed elevated levels (P Ͻ 0.01) of NCX protein in VO rat hearts (Fig. 9) . 
DISCUSSION
There were several major findings in the VO rats in the present study. LV ESPVR shifted downward, and thus mean ESP mLVV and mean eE max,mLVV (at an mLVV) were significantly decreased compared with those in the Sham rats, indicating systolic dysfunction. The contractile response to Ca 2ϩ infusion (␦ESP mLVV ) was significantly smaller in the VO rats than in the Sham rats. The mean slope of the V O 2 -PVA relation was hardly changed, but the V O 2 intercept was significantly decreased with unchanged basal metabolism compared with those in the Sham rat, indicating the decreased Ca 2ϩ handlingrelated V O 2 at baseline. Finally, the mean slope of the relationship between Ca 2ϩ handling-related V O 2 and eE max was significantly increased, indicating a less efficient energy utilization in the Ca 2ϩ handling process.
Mechanical Function after AV Shunt
The VO rats created in the present study mainly showed LV systolic dysfunction, whereas diastolic function was almost unchanged. This is compatible with previous studies in a similar VO model in which LV eccentric hypertrophy and systolic dysfunction were apparent, whereas diastolic function and compliance of the ventricle were unchanged or enhanced (4) . It is generally accepted that derangement of intracellular Ca 2ϩ handling can play a crucial role in the development of the systolic and diastolic dysfunction accompanying arrhythmia. The mechanism of the LV contractile dysfunction in the present study can be also explained by a derangement of the Ca 2ϩ handling process involved in E-C coupling. . The V O2 intercept was smaller in the VO heart than in the Sham heart, but the slopes were similar in both VO and Sham hearts. Fig. 7 . Representative PVA-independent V O2-equivalent maximal elastance (eEmax) midrange LV volume data and best-fit regression line (the PVAindependent V O2-eEmax linear relation; the slope of the relation is the O2 cost of LV contractility). The O2 cost of LV contractility in this VO heart was higher than that in the Sham heart. 
Ca 2ϩ Handling in E-C Coupling
We have previously reported that Ca 2ϩ overload in the cytoplasm due to the impairment of the total Ca 2ϩ handling in E-C coupling in the myocardium induced acute cardiac failure (19 handling is induced mainly by the enhanced NCX activity. In the present study, the expression of the NCX protein was increased in the VO LV tissue. We also reported the same kinds of increased O 2 consumption related to increased NCX activity in a PO hypertrophied rat heart (15). In the failing human heart, a reduction in SERCA2a expression and an increase in NCX expression have been reported (2, 9) . This theory was supported by the result in the present study that the SERCA2a protein level was decreased and the NCX protein level was elevated in VO rat hearts. Therefore, in the VO rats, decreased Ca 2ϩ uptake via the SERCA2a pump has impaired cardiac contractility and simultaneously induced energy wasting in E-C coupling.
Another possibility for higher O 2 cost of LV contractility is due to leaky ryanodine receptors. Leaky ryanodine receptors can cause higher cytosolic Ca 2ϩ concentrations in diastole (23), suggesting the possibility for increased energy expenditure by SERCA2a pump. However, the latter hypothesis is unlikely to explain all our findings; indeed, the protein level of SERCA2a in the VO rat hearts was lower than that in the Sham rat hearts, unless NCX1 is upregulated.
A third possibility is due to a lower Ca 2ϩ sensitivity of the myofilament, since ␦ESP mLVV induced by Ca 2ϩ infusion was significantly smaller in the VO rat hearts (see Table 2 ). However, the increase of PVA-independent V O 2 was actually larger in the VO rat heart than that in the Sham rat heart under the same protocol for Ca 2ϩ infusion (see Fig. 7 ). Therefore, the higher O 2 cost of LV contractility seems rather to derive from the larger increase of PVA-independent V O 2 .
Taken together, the possibility that Ca 2ϩ uptake via the SERCA2a pump is suppressed and instead NCX activity is enhanced is the most likely explanation for our findings (15) , although further studies including SERCA2a overexpression by gene transfer are needed to verify this possibility.
Chemomechanical Energy Transduction
In the VO hearts, the slope of the V O 2 -PVA relation was almost unchanged or slightly lower compared with that of the Sham heart. The slope of the V O 2 -PVA relation remained unchanged in hypothyroid (11) and diabetic (1) rat hearts, whereas a steeper slope of the V O 2 -PVA relation was reported in hyperthyroid rabbit hearts. It was reported that the slope of the V O 2 -PVA relation was related to the ratio of the myosin isoform component from predominantly V3 to predominantly V1 (i.e., the slope of the V O 2 -PVA relation increases when the V1-to-V3 ratio increases, and the slope of the V O 2 -PVA relation is unchanged when the V1-to-V3 ratio decreases) (6) . It was also reported that a progressive decrease in V1 and an increase in V3 were apparent in the LV 8-to 16 wk after AV shunt (21) . This report is consistent with the almost unchanged slope of the V O 2 -PVA relation in the VO rats. The slope of V O 2 -PVA relation reflects the ratio of chemomechanical energy transduction efficiency of the contractile machinery. Therefore, in the VO rats, energy wasting is not related to chemomechanical energy transduction.
Conclusion
VO failing rat hearts had a character of marked contractile dysfunction accompanied with inefficient energy utilization especially in E-C coupling.
Present results suggest that restoring the Ca 2ϩ handling process in E-C coupling would improve myocardial contractility in the setting of eccentric cardiac remodeling.
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